Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (562)	5/21/1999 5:28:00 PM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 1494

Wow! I spent the day in meetings and missed all the fun. I'm sorry that I wasn't here to sooth the group with some good old fashioned technical abstracts :-). Was this due to spam? I think it must be. I recently talked with Paul Freiman and there were no indications of anything eminent on the horizon. Everything is going well. The Diabetic Neuropathy trial is enrolling patients ahead of schedule and should be fully enrolled in July. Negotiations are ongoing for a partner for Memantine. I understand that Merz rejected one offer and there are still two pharmas in the hunt. We may hear something in June, but it may be later. So, unless there's some big surprise out there that I've gotten no inkling of, there shouldn't be any big news immediately. So, my guess is that it was the spam that moved the stock. I, like Mike, hate the stuff. But, it's amazing how a pop in your largest position can change your attitude toward spam :-) I agree with Jeffrey that this was not a typical spam; all hype no substance. So, maybe this spam-rally will have some legs. It appears to be based on some of the truths about NTII that attracted us to the stock in the first place. The fact that the spam-rally closed strong suggests that day trader were not involved. So, maybe all the buying has put stock in some reasonable and steady hands. Let's hope so. Monday will be interesting. John de C